Cholecystokinin receptors in relation to brain dopaminergic pathways.
Parke-Davis Research Unit, Addenbrookes Hospital, Cambridge, U.K.
G N
GN
Woodruff
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism*; D004594:Electrophysiology; D006801:Humans; D009434:Neural Pathways / Q000378:metabolism; D011949:Receptors, Cholecystokinin / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology
D014151:Anti-Anxiety Agents; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D004298:Dopamine